Quest Diagnostics Q1 Net Falls, Revenue Guidance Trimmed

Quest Diagnostics'  (NYSE: DGX  )  first-quarter results have been released. For the quarter, net revenues were just under $1.79 billion, a drop from the $1.91 billion in the same period the previous year. Attributable net profit also declined, to $136 million ($0.85 per diluted share) from Q1 2012's result of $159 million ($0.99).

The most recent quarter's numbers fell short of average analyst estimates, which were for $1.86 billion in top line and EPS of $1.03.

Quest Diagnostics also updated its forward guidance for fiscal 2013. The company now believes its revenues will roughly equal those of 2012, a slight downward adjustment to its previous growth anticipation of 0%-1% year over year. The firm maintained its EPS forecast of $4.35-$4.55 for the year.


Read/Post Comments (0) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

DocumentId: 2369587, ~/Articles/ArticleHandler.aspx, 4/23/2014 6:14:12 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...


Advertisement